Naive Pluripotent and Trophoblastic Stem Cell Lines as a Model for Detecting Missing Proteins in the Context of the Chromosome-Centric Human Proteome Project.

human naive pluripotent stem cells human proteome project human trophoblastic stem cells missing proteins

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
07 04 2023
Historique:
medline: 10 4 2023
pubmed: 30 11 2022
entrez: 29 11 2022
Statut: ppublish

Résumé

The Chromosome-centric Human Proteome Project (C-HPP) aims at identifying the proteins as gene products encoded by the human genome, characterizing their isoforms and functions. The existence of products has now been confirmed for 93.2% of the genes at the protein level. The remaining mostly correspond to proteins of low abundance or difficult to access. Over the past years, we have significantly contributed to the identification of missing proteins in the human spermatozoa. We pursue our search in the reproductive sphere with a focus on early human embryonic development. Pluripotent cells, developing into the fetus, and trophoblast cells, giving rise to the placenta, emerge during the first weeks. This emergence is a focus of scientists working in the field of reproduction, placentation and regenerative medicine. Most knowledge has been harnessed by transcriptomic analysis. Interestingly, some genes are uniquely expressed in those cells, giving the opportunity to uncover new proteins that might play a crucial role in setting up the molecular events underlying early embryonic development. Here, we analyzed naive pluripotent and trophoblastic stem cells and discovered 4 new missing proteins, thus contributing to the C-HPP. The mass spectrometry proteomics data was deposited on ProteomeXchange under the data set identifier PXD035768.

Identifiants

pubmed: 36445260
doi: 10.1021/acs.jproteome.2c00496
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1148-1158

Auteurs

Océane Girard (O)

Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, F-44000Nantes, France.

Régis Lavigne (R)

Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000Rennes, France.
Univ Rennes, CNRS, Inserm, Biosit UAR 3480 US_S 018, Protim Core Facility, F-35000Rennes, France.

Simon Chevolleau (S)

Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, F-44000Nantes, France.

Constance Onfray (C)

Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, F-44000Nantes, France.

Emmanuelle Com (E)

Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000Rennes, France.
Univ Rennes, CNRS, Inserm, Biosit UAR 3480 US_S 018, Protim Core Facility, F-35000Rennes, France.

Pierre-Olivier Schmit (PO)

Bruker Daltonique SA, 34 rue de l'Industrie, F-67166Wissembourg cedex, France.

Manuel Chapelle (M)

Bruker Daltonique SA, 34 rue de l'Industrie, F-67166Wissembourg cedex, France.

Thomas Fréour (T)

Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, F-44000Nantes, France.
CHU Nantes, Service de Biologie de la Reproduction, F-44000Nantes, France.
Department of Obstetrics, Gynecology and Reproductive Medicine, Dexeus University Hospital, 08028Barcelona, Spain.

Lydie Lane (L)

CALIPHO Group, SIB Swiss Institute of Bioinformatics and University of Geneva, CH-1211Geneva, Switzerland.

Laurent David (L)

Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, F-44000Nantes, France.
Nantes Université, CHU Nantes, Inserm, CNRS, BioCore, F-44000Nantes, France.

Charles Pineau (C)

Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000Rennes, France.
Univ Rennes, CNRS, Inserm, Biosit UAR 3480 US_S 018, Protim Core Facility, F-35000Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH